Chromium Alleviates Glucose Intolerance, Insulin Resistance, and Hepatic ER Stress in Obese Mice
Authors:
Open Access
Abstract
Objective: Chromium has gained popularity as a nutritional supplement for diabetic patients. This study evaluated the effect of chronic administration of a chromium complex of d‐phenylalanine (Cr(d‐phe)3) on glucose and insulin tolerance in obese mice. The study tested the hypothesis that Cr(d‐phe)3 suppresses endoplasmic reticulum (ER) stress and insulin resistance in these animals.Methods and Procedures: C57BL lean and ob/ob obese mice were randomly divided to orally receive vehicle or Cr(d‐phe)3 (3.8 μg of elemental chromium/kg/day) for 6 months. Insulin sensitivity was evaluated by glucose and insulin tolerance tests. Protein levels of phosphorylated pancreatic ER kinase (PERK), α subunit of translation initiation factor 2 (eIF2α) and inositol‐requiring enzyme‐1 (IRE‐1), p‐c‐Jun, and insulin receptor substrate‐1 (IRS‐1) phosphoserine‐307 were assessed by western blotting. In vitro ER stress was induced by treating cultured muscle cells with thapsigargin in the presence or absence of Cr(d‐phe)3.Results: ob/ob mice showed poor glucose and insulin tolerance compared to the lean controls, which was attenuated by Cr(d‐phe)3. Markers of insulin resistance (phospho‐c‐Jun and IRS‐1 phosphoserine) and ER stress (p‐PERK, p‐IRE‐1, p‐eIF2α), which were elevated in ob/ob mice, were attenuated following Cr(d‐phe)3 treatment. Chromium treatment was also associated with a reduction in liver triglyceride levels and lipid accumulation. In cultured myotubes, Cr(d‐phe)3 attenuated ER stress induced by thapsigargin.Discussion: Oral Cr(d‐phe)3 treatment reduces glucose intolerance, insulin resistance, and hepatic ER stress in obese, insulin‐resistant mice.Keywords
This publication has 27 references indexed in Scilit:
- Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditionsMutation Research - Genetic Toxicology and Environmental Mutagenesis, 2006
- Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 DiabetesScience, 2006
- Insulin-sensitizing and cholesterol-lowering effects of chromium (d-Phenylalanine)3Journal of Inorganic Biochemistry, 2006
- A newly synthetic chromium complex – chromium(phenylalanine)3 improves insulin responsiveness and reduces whole body glucose toleranceFEBS Letters, 2005
- Fat in the liver and insulin resistanceAnnals of Medicine, 2005
- Involvement of Endoplasmic Reticulum Stress in Insulin Resistance and DiabetesJournal of Biological Chemistry, 2005
- Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 DiabetesScience, 2004
- Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Recent advances in the nutritional biochemistry of trivalent chromiumProceedings of the Nutrition Society, 2004
- Minireview: Serine Phosphorylation of Insulin Receptor Substrate-1: A Novel Target for the Reversal of Insulin ResistanceMolecular Endocrinology, 2001